Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter's Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Growth in adoption of immunotherapy over other treatment options
4.1.2 Increased development of bioinformatic tools enhancing drug development process
4.2 Restraints
4.2.1 Cost issues
4.3 Opportunities
4.3.1 Rising number of clinical trials against many types of cancers in immunotherapy
4.3.2 Increased growth prospects in developing countries
4.4 Challenges
4.4.1 Limited funds for the initiation of clinical trials
4.4.2 Complexity of cancers
Chapter 5 Middle East and Africa Cancer Immunotherapy Market – By Production
5.1 Checkpoint Inhibitors
5.2 Monoclonal Antibodies
5.3 Cell Therapies
5.4 Immunomodulators
Chapter 6 the Middle East and Africa Cancer Immunotherapy Market – By Application
6.1 Colorectal Cancer
6.2 Melanoma
6.3 Prostate Cancer
6.4 Lung Cancer
6.5 Head & Neck Cancer
6.6 Multiple Myeloma
6.7 Breast Cancer
6.8 Others
Chapter 7 Middle East and Africa Cancer Immunotherapy Market - By End-user
7.1 Hospitals
7.2 Clinics
7.3 Others
Chapter 8 Middle East and Africa Cancer Immunotherapy Market - By Geography
8.1 Introduction
8.2 Middle East & Africa
8.2.1 Middle East
8.2.2 Africa
Chapter 9 Middle East and Africa Cancer Immunotherapy Market - Company Profiles
9.1 AstraZeneca Plc
9.2 ELI Lilly and Company
9.3 Bayer AG
9.4. Novartis International AG
9.5 F. Hoffmann-La Roche Ltd
9.6 Janssen Global Services, LLC (Johnson and Johnson)
9.7 Pfizer Inc
9.8 Merck & Company, Inc.
9.9 Amgen Inc.
Chapter 10 Middle East and Africa Cancer Immunotherapy Market - Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 11 Market Insights
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
